Dermatology Doctors in Silverdale, WA Accepting Medicare

4 Dermatology doctors found. Showing 1 - 4

Michael Scott Metzman, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 9951 Mickelberry Rd Nw, Suite 201, Silverdale, WA 98383 Phone: 360-692-7318    Fax: 360-308-0758

Daniel Kim Frum, M.D. Dermatology Medicare: Not Enrolled in Medicare Practice Location: 2011 Nw Myhre Pl, Silverdale, WA 98383 Phone: 360-830-1701

Eric O Rasmussen, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 3505 Nw Anderson Hill Rd, #201, Silverdale, WA 98383 Phone: 360-698-6859    Fax: 360-337-7403

Dr. Robert Francis Butler, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 10452 Silverdale Way Nw, Silverdale, WA 98383 Phone: 360-307-7300    Fax: 360-307-7304

News Archive

Firms pursue new digital technologies to meet stimulus- and health law-fueled provider demand

The Washington Post: "A growing number of companies are joining five-year-old AFrame Digital in offering products that link heath care with mobile and other remote technologies in an effort to increase the quality and reduce the cost of medical treatment. Health-care legislation made heaps of money available to digitize medical records and bolster the industry's information technology, including programs to foster innovation" (Overly, 11/8).

USPTO issues notice of allowance to MDI's PCR-based technology platform

Molecular Detection Inc. (MDI), a company developing Detect-Ready assays designed to increase the speed and accuracy of infectious disease diagnosis, today announced that it has received a notice of allowance from the US Patent and Trademark Office (USPTO) for a patent application titled "Methods, Compositions and Kits for Detection and Analysis of Antibiotic Resistant Bacteria."

Cancer cells maintain rapid proliferation due to PK-M2 enzyme

Cancer cells maintain their life-style of extremely rapid growth and proliferation thanks to an enzyme called PK-M2 (pyruvate kinase M2) that alters the cells' ability to metabolize glucose - a phenomenon known as the Warburg effect.

Interim data comparing Cervista HPV HR to Hybrid Capture 2 presented at 4th Biennial Meeting of AOGIN

Hologic, Inc., a leading developer, manufacturer and supplier of premium diagnostics, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, today announced that interim data from the first large-scale independent evaluation of clinical performance of Cervista® HPV HR compared to Hybrid Capture 2 (hc2), were presented at the 4th Biennial Meeting of AOGIN (Asia-Oceanic Research Organization in Genital Infection and Neoplasia) in New Delhi, India on March 26-28, 2010.

Read more Medical News

› Verified 1 days ago